{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:02:15Z","timestamp":1784847735090,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04945-9","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T07:34:02Z","timestamp":1779867242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of CT-defined sarcopenic obesity in hepatocellular carcinoma patients undergoing transarterial chemoembolization"],"prefix":"10.1186","volume":"26","author":[{"given":"Settawit","family":"Chatsuntiprapa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kittipitch","family":"Bannangkoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teeravut","family":"Tubtawee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natee","family":"Ina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"4945_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J Clin. 2021;71:209\u201349.","journal-title":"Cancer J Clin"},{"key":"4945_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol. 2022;76:681\u201393.","journal-title":"J Hepatol"},{"key":"4945_CR3","doi-asserted-by":"crossref","unstructured":"Lucatelli P, Guiu B. 2022 Update of BCLC Treatment Algorithm of HCC: What\u2019s New for Interventional Radiologists? Cardiovascular and Interventional Radiology. 2022;45:275\u2009\u2013\u200976.","DOI":"10.1007\/s00270-021-03047-1"},{"key":"4945_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000507370","volume":"9","author":"M Kudo","year":"2020","unstructured":"Kudo M, Han KH, Ye SL, et al. A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements. Liver Cancer. 2020;9:245\u201360.","journal-title":"Liver Cancer"},{"key":"4945_CR5","doi-asserted-by":"publisher","first-page":"1233973","DOI":"10.3389\/fnut.2023.1233973","volume":"10","author":"X Li","year":"2023","unstructured":"Li X, Huang X, Lei L, et al. Impact of sarcopenia and sarcopenic obesity on survival in patients with primary liver cancer: a systematic review and meta-analysis. Front Nutr. 2023;10:1233973.","journal-title":"Front Nutr"},{"key":"4945_CR6","first-page":"389","volume":"16","author":"J Long","year":"2024","unstructured":"Long J, Zhang X, Mi W, et al. The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients. Aging. 2024;16:389\u2013401.","journal-title":"Aging"},{"key":"4945_CR7","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.3748\/wjg.v28.i36.5324","volume":"28","author":"G Roth","year":"2022","unstructured":"Roth G, Teyssier Y, Benhamou M, et al. Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization. World J Gastroenterol. 2022;28:5324\u201337.","journal-title":"World J Gastroenterol"},{"key":"4945_CR8","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1080\/07853890.2022.2081872","volume":"54","author":"JX Zhang","year":"2022","unstructured":"Zhang JX, Yan HT, Ding Y, et al. Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization. Ann Med. 2022;54:1562\u201369.","journal-title":"Ann Med"},{"key":"4945_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2147\/JHC.S407646","volume":"10","author":"S Wang","year":"2023","unstructured":"Wang S, Zhang X, Chen Q, et al. A Novel Neutrophil-to-Lymphocyte Ratio and Sarcopenia Based TACE-Predict Model of Hepatocellular Carcinoma Patients. J Hepatocellular Carcinoma. 2023;10:659\u201371.","journal-title":"J Hepatocellular Carcinoma"},{"key":"4945_CR10","doi-asserted-by":"publisher","first-page":"e0232371","DOI":"10.1371\/journal.pone.0232371","volume":"15","author":"E Lanza","year":"2020","unstructured":"Lanza E, Masetti C, Messana G, et al. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma. PLoS ONE. 2020;15:e0232371.","journal-title":"PLoS ONE"},{"key":"4945_CR11","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.1007\/s00432-022-04519-8","volume":"149","author":"SH Loosen","year":"2023","unstructured":"Loosen SH, J\u00f6rdens MS, Schoon B, et al. Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies. J Cancer Res Clin Oncol. 2023;149:6181\u201390.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4945_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1507\/endocrj.EJ23-0593","volume":"71","author":"W Ogawa","year":"2024","unstructured":"Ogawa W, Hirota Y, Miyazaki S, et al. Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan. Endocr J. 2024;71:223\u201331.","journal-title":"Endocr J"},{"key":"4945_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/gastro\/goz040","volume":"8","author":"ZX Chen","year":"2019","unstructured":"Chen ZX, Jian ZW, Wu XW, et al. Impact of overweightness and critical weight loss on overall survival in patients with hepatocellular carcinoma initially treated with chemoembolization. Gastroenterol Rep. 2019;8:125\u201333.","journal-title":"Gastroenterol Rep"},{"key":"4945_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000488779","volume":"8","author":"Y Hamaguchi","year":"2019","unstructured":"Hamaguchi Y, Kaido T, Okumura S, et al. Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma. Liver Cancer. 2019;8:92\u2013109.","journal-title":"Liver Cancer"},{"key":"4945_CR15","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3390\/cancers11081206","volume":"11","author":"K Imai","year":"2019","unstructured":"Imai K, Imai K, Takai K, et al. Rapid Depletions of Subcutaneous Fat Mass and Skeletal Muscle Mass Predict Worse Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Cancers (Basel). 2019;11:1206.","journal-title":"Cancers (Basel)"},{"key":"4945_CR16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/SLA.0000000000002555","volume":"269","author":"A Kobayashi","year":"2019","unstructured":"Kobayashi A, Kaido T, Hamaguchi Y, et al. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Ann Surg. 2019;269:924\u201331.","journal-title":"Ann Surg"},{"key":"4945_CR17","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1245\/s10434-017-6077-y","volume":"24","author":"S Okumura","year":"2017","unstructured":"Okumura S, Kaido T, Hamaguchi Y, et al. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer. Ann Surg Oncol. 2017;24:3732\u201340.","journal-title":"Ann Surg Oncol"},{"key":"4945_CR18","doi-asserted-by":"publisher","first-page":"111704","DOI":"10.1016\/j.nut.2022.111704","volume":"101","author":"Q Gao","year":"2022","unstructured":"Gao Q, Hu K, Gao J, et al. Prevalence and prognostic value of sarcopenic obesity in patients with cancer: A systematic review and meta-analysis. Nutrition. 2022;101:111704.","journal-title":"Nutrition"},{"key":"4945_CR19","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.clnu.2022.01.033","volume":"41","author":"W Ji","year":"2022","unstructured":"Ji W, Liu X, Zheng K, et al. Thresholds of visceral fat area and percent of body fat to define sarcopenic obesity and its clinical consequences in Chinese cancer patients. Clin Nutr. 2022;41:737\u201345.","journal-title":"Clin Nutr"},{"key":"4945_CR20","doi-asserted-by":"publisher","first-page":"e0125649","DOI":"10.1371\/journal.pone.0125649","volume":"10","author":"Z Guo","year":"2015","unstructured":"Guo Z, Zhang J, Jiang JH, et al. Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy. PLoS ONE. 2015;10:e0125649.","journal-title":"PLoS ONE"},{"key":"4945_CR21","doi-asserted-by":"publisher","first-page":"430438","DOI":"10.1155\/2013\/430438","volume":"2013","author":"H Nishikawa","year":"2013","unstructured":"Nishikawa H, Arimoto A, Wakasa T, Kita R, Kimura T, Osaki Y. The Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma. Gastroenterol Res Pract. 2013;2013:430438.","journal-title":"Gastroenterol Res Pract"},{"key":"4945_CR22","first-page":"173","volume":"22","author":"H Nishikawa","year":"2013","unstructured":"Nishikawa H, Osaki Y, Takeda H, et al. Effect of body mass index on survival after curative therapy for non-B non-C hepatocellular carcinoma. J Gastrointest Liver Dis. 2013;22:173\u201381.","journal-title":"J Gastrointest Liver Dis"},{"key":"4945_CR23","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.jmir.2022.10.122","volume":"53","author":"J Cheewakul","year":"2022","unstructured":"Cheewakul J, Yanaihap N, Yue-roh T, et al. A deep learning for automated segmentation of skeletal muscle at the third lumbar vertebra in computed tomography images. J Med Imaging Radiation Sci. 2022;53:S37.","journal-title":"J Med Imaging Radiation Sci"},{"key":"4945_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jhep.2015.02.031","volume":"63","author":"N Fujiwara","year":"2015","unstructured":"Fujiwara N, Nakagawa H, Kudo Y, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63:131\u201340.","journal-title":"J Hepatol"},{"key":"4945_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/07853890.2010.526138","volume":"44","author":"A Hiuge-Shimizu","year":"2012","unstructured":"Hiuge-Shimizu A, Kishida K, Funahashi T, et al. Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study). Ann Med. 2012;44:82\u201392.","journal-title":"Ann Med"},{"key":"4945_CR26","doi-asserted-by":"publisher","first-page":"e25237","DOI":"10.1016\/j.heliyon.2024.e25237","volume":"10","author":"A Wang","year":"2024","unstructured":"Wang A, Li J, Li C, et al. Impact of body composition on the prognosis of hepatocellular carcinoma patients treated with transarterial chemoembolization: A systematic review and meta-analysis. Heliyon. 2024;10:e25237.","journal-title":"Heliyon"},{"key":"4945_CR27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s11914-020-00628-w","volume":"18","author":"X Zhong","year":"2020","unstructured":"Zhong X, Zimmers TA. Sex Differences in Cancer Cachexia. Curr Osteoporos Rep. 2020;18:646\u201354.","journal-title":"Curr Osteoporos Rep"},{"key":"4945_CR28","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jhep.2016.06.007","volume":"65","author":"M Sinclair","year":"2016","unstructured":"Sinclair M, Grossmann M, Hoermann R, et al. Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial. J Hepatol. 2016;65:906\u201313.","journal-title":"J Hepatol"},{"key":"4945_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3389\/fendo.2019.00720","volume":"10","author":"BR Counts","year":"2019","unstructured":"Counts BR, Fix DK, Hetzler KL, Carson JA. The Effect of Estradiol Administration on Muscle Mass Loss and Cachexia Progression in Female ApcMin\/+ Mice. Front Endocrinol. 2019;10:720.","journal-title":"Front Endocrinol"},{"key":"4945_CR30","doi-asserted-by":"publisher","first-page":"bqac058","DOI":"10.1210\/endocr\/bqac058","volume":"163","author":"BC \u00d6zdemir","year":"2022","unstructured":"\u00d6zdemir BC, Gerard CL, Espinosa da Silva C. Sex and Gender Differences in Anticancer Treatment Toxicity: A Call for Revisiting Drug Dosing in Oncology. Endocrinology. 2022;163:bqac058.","journal-title":"Endocrinology"},{"key":"4945_CR31","doi-asserted-by":"publisher","first-page":"8347","DOI":"10.1038\/s41598-020-65460-9","volume":"10","author":"B Cha","year":"2020","unstructured":"Cha B, Yu JH, Jin YJ, et al. Survival Outcomes According to Body Mass Index in Hepatocellular Carcinoma Patient: Analysis of Nationwide Cancer Registry Database. Sci Rep. 2020;10:8347.","journal-title":"Sci Rep"},{"key":"4945_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4254\/wjh.v16.i3.393","volume":"16","author":"AS deLemos","year":"2024","unstructured":"deLemos AS, Zhao J, Patel M, et al. Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma. World J Hepatol. 2024;16:393\u2013404.","journal-title":"World J Hepatol"},{"key":"4945_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/14737140.2025.2489651","volume":"25","author":"QB Wang","year":"2025","unstructured":"Wang QB, Li J, Zhang ZJ, et al. The Effectiveness and Safety of Therapies for Hepatocellular Carcinoma with Tumor Thrombus in the Hepatic Vein, Inferior Vena Cava and\/or Right Atrium: A Systematic Review and Single-Arm Meta-Analysis. Expert Rev Anticancer Ther. 2025;25:561\u201370.","journal-title":"Expert Rev Anticancer Ther"},{"key":"4945_CR34","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.7150\/jca.92976","volume":"15","author":"Y Bai","year":"2024","unstructured":"Bai Y, Liu J, Wang Y, et al. Impact of Sarcopenia on Prognosis in Primary Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Single Center Retrospective Study. J Cancer. 2024;15:1837\u201347.","journal-title":"J Cancer"},{"key":"4945_CR35","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1038\/s41598-023-31184-9","volume":"13","author":"K Bannangkoon","year":"2023","unstructured":"Bannangkoon K, Hongsakul K, Tubtawee T, et al. Association of myosteatosis with treatment response and survival in patients with hepatocellular carcinoma undergoing chemoembolization: a retrospective cohort study. Sci Rep. 2023;13:3978.","journal-title":"Sci Rep"},{"key":"4945_CR36","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.2147\/JHC.S556306","volume":"12","author":"WL Luo","year":"2025","unstructured":"Luo WL, Wang QB, Li YK, et al. Impact of Middle Hepatic Vein Resection During Hemihepatectomy on Surgical Outcomes and Long-Term Prognosis in Hepatocellular Carcinoma: A Retrospective Study. J Hepatocell Carcinoma. 2025;12:2681\u201392.","journal-title":"J Hepatocell Carcinoma"},{"key":"4945_CR37","doi-asserted-by":"publisher","first-page":"E81","DOI":"10.1097\/NCC.0000000000000957","volume":"46","author":"MK Jang","year":"2023","unstructured":"Jang MK, Park C, Tussing-Humphreys L, Fernhall B, et al. The Effectiveness of Sarcopenia Interventions for Cancer Patients Receiving Chemotherapy: A Systematic Review and Meta-analysis. Cancer Nurs. 2023;46:E81\u201390.","journal-title":"Cancer Nurs"},{"key":"4945_CR38","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1186\/s12885-024-13023-w","volume":"24","author":"D Gennuso","year":"2024","unstructured":"Gennuso D, Baldelli A, Gigli L, et al. Efficacy of Prehabilitation in cancer patients: an RCTs systematic review with meta-analysis. BMC Cancer. 2024;24:1302.","journal-title":"BMC Cancer"},{"key":"4945_CR39","doi-asserted-by":"crossref","unstructured":"Li J, Liang YB, Wang QB et al. Rechallenge with Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma: A Narrative Review. Liver Cancer. 2026. In press.","DOI":"10.1159\/000549355"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04945-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T22:46:10Z","timestamp":1784846770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04945-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4945"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04945-9","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the guidelines of the Declaration of Helsinki and was approved by the Institutional Review Board of the Faculty of Medicine, Prince of Songkla University and Songklanagarind Hospital (REC. 67-382-7-4, approved on 18 September 2024).The requirement for written informed consent was waived by the Institutional Review Board of the Faculty of Medicine, Prince of Songkla University, due to the retrospective nature of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"472"}}